UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 374

Sortiert nach

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

Journal of clinical oncology, 2005-06, Vol.23 (18), p.4117-4126

2005

Volltextzugriff (PDF)

Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy

Annals of hematology, 2008-05, Vol.87 (5), p.429-430

2008

Volltextzugriff (PDF)

Low-Dose 5-Aza-2′-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients

Journal of clinical oncology, 2000-03, Vol.18 (5), p.956-962

2000

Volltextzugriff (PDF)

Unmet needs in the scientific approach to older patients with lymphoma

Haematologica (Roma), 2017-06, Vol.102 (6), p.972

2017

Volltextzugriff (PDF)

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

Nature genetics, 2004-10, Vol.36 (10), p.1084-1089

2004

Volltextzugriff (PDF)

Late Effect of the Cervical Irradiation on Periodontal Status and Cariogen Flora in Hodgkin Lymphoma Patients

ISRN hematology, 2011-01, Vol.2011, p.823926-5

2011

Volltextzugriff (PDF)

Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

Annals of hematology, 2008-04, Vol.87 (4), p.277-283

2008

Volltextzugriff (PDF)

Larvicidal activity of Thymus Vulgaris Essential oil against Aedes Aegypti L. (Diptera: Culicidae)

Indian journal of entomology, 2015-12, Vol.77 (4), p.405-409

2015

Volltextzugriff (PDF)

LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

RITUXIMAB IN COMBINATION WITH BENDAMUSTINE OR HIGH‐DOSE CYTARABINE‐BASED INDUCTION THERAPY IN TRANSPLANT‐ELIGIBLE PATIENTS WITH MANTLE CELL LYMPHOMA

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital

Clinical microbiology and infection, 2006-06, Vol.12 (6), p.527-532

2006

Volltextzugriff (PDF)

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d’Etude des Lymphomes de l’Adulte (GELA)

Annals of oncology, 2010-04, Vol.21 (4), p.842-850

2010

Volltextzugriff (PDF)

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

The New England journal of medicine, 2017-09, Vol.377 (13), p.1250-1260

2017

Volltextzugriff (PDF)

An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients

Annals of hematology, 2005-12, Vol.84 Suppl 1 (S1), p.9-17

2005

Volltextzugriff (PDF)

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia

Leukemia, 2009-01, Vol.23 (1), p.125-133

2009

Volltextzugriff (PDF)

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

The New England journal of medicine, 2015-03, Vol.372 (10), p.944-953

2015

Volltextzugriff (PDF)

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

The lancet oncology, 2018-11, Vol.19 (11), p.1449-1458

2018

Volltextzugriff (PDF)

Cytarabine Dose for Acute Myeloid Leukemia

The New England journal of medicine, 2011-03, Vol.364 (11), p.1027-1036

2011

Volltextzugriff (PDF)

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma : Updated results of the prospective study LNH87-2

Journal of clinical oncology, 1997-03, Vol.15 (3), p.1131-1137

1997

Volltextzugriff (PDF)

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

The New England journal of medicine, 2009-09, Vol.361 (13), p.1235-1248

2009

Volltextzugriff (PDF)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats

Advances in Hematology, 2011, Vol.2011, p.430679-6

2011

Volltextzugriff (PDF)

Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation

ISRN hematology, 2013-06, Vol.2013, p.847672-7

2013

Volltextzugriff (PDF)

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial

Annals of oncology, 2014-08, Vol.25 (8), p.1622-1628

2014

Volltextzugriff (PDF)

1 – 25 von 374

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(309)
Mit Volltextzugriff
(270)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(193)
Science & Technology
(175)
Life Sciences & Biomedicine
(174)
Middle Aged
(130)
Female
(124)
Male
(122)
Adult
(110)
Biological And Medical Sciences
(97)
Medical Sciences
(96)
Aged
(92)
Hematology
(83)
Oncology
(77)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(62)
Hematologic And Hematopoietic Diseases
(46)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(43)
Adolescent
(38)
Aged, 80 And Over
(37)
Pharmacology. Drug Treatments
(37)
Treatment Outcome
(35)
Chemotherapy
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy

Low-Dose 5-Aza-2′-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients

Unmet needs in the scientific approach to older patients with lymphoma

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

Late Effect of the Cervical Irradiation on Periodontal Status and Cariogen Flora in Hodgkin Lymphoma Patients

Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

Larvicidal activity of Thymus Vulgaris Essential oil against Aedes Aegypti L. (Diptera: Culicidae)

LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL

RITUXIMAB IN COMBINATION WITH BENDAMUSTINE OR HIGH‐DOSE CYTARABINE‐BASED INDUCTION THERAPY IN TRANSPLANT‐ELIGIBLE PATIENTS WITH MANTLE CELL LYMPHOMA

A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d’Etude des Lymphomes de l’Adulte (GELA)

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

An epigenetic approach to the treatment of advanced MDS; the experience with the DNA demethylating agent 5-aza-2'-deoxycytidine (decitabine) in 177 patients

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Cytarabine Dose for Acute Myeloid Leukemia

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma : Updated results of the prospective study LNH87-2

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats

Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial

Suchergebnisse filtern